IP Library › Granted Patent US 12,133,936
Granted Patent B2
US 12,133,936 · App. 17/142,694 · Granted Nov 5, 2024

Surgical system and methods of use

Inventors: Christian S. Nielsen (River Falls, WI); Sean Chen (Plymouth, MN); Anne R. Kamm (White Bear Lake, MN); Paul C. Ray (Maple Grove, MN)
Assignee: Medtronic, Inc
A61L31/16A61K9/0024A61K31/137A61K31/195A61K31/496A61K31/65A61K31/717A61K31/722A61K45/06A61K47/42A61L31/044A61L31/10A61F2/0077A61F2250/0067A61L33/18A61N1/37518
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,133,936
App. No.
17/142,694
Granted
Nov 5, 2024
Kind
B2
Abstract

A surgical device configured to surround an implantable medical device that includes a collagen membrane and a coating embedded in the membrane, the coating including at least one active pharmaceutical ingredient.

Claims (27)

1. A surgical device configured to surround an implantable medical device, the surgical device comprising:

a collagen membrane; and

a coating covering at least a portion of the membrane, the coating including an active pharmaceutical ingredient and carboxypeptidase collagen,

wherein the membrane is free of extracellular matrix collagen.

2. The surgical device recited in claim 1 , wherein the active pharmaceutical ingredient is selected from the group consisting of anesthetics, antibiotics, anti-inflammatory agents, procoagulant agents, fibrosis-inhibiting agents, anti-scarring agents, leukotriene inhibitors/antagonists, cell growth inhibitors and mixtures thereof.

3. The surgical device recited in claim 1 , wherein the active pharmaceutical ingredient is a mixture of rifampin and minocycline.

4. The surgical device recited in claim 1 , wherein the active pharmaceutical ingredient is selected from the group consisting of a hemostatic agent, rifampin and minocycline, and mixtures thereof.

5. The surgical device recited in claim 4 , wherein the hemostatic agent is selected from a group consisting of epinephrine, tranexamic acid, chitosan and oxidized regenerated cellulose, and mixtures thereof.

6. The surgical device recited in claim 1 , wherein the active pharmaceutical ingredient is selected from the group consisting of a peptide, rifampin and minocycline, and mixtures thereof.

7. The surgical device recited in claim 1 , wherein the active pharmaceutical ingredient is selected from the group consisting of a pain medication, rifampin and minocycline, and mixtures thereof.

8. The surgical device recited in claim 1 , wherein the membrane comprises a first piece and a second piece that is joined with the first piece, the first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity, the implantable medical device being configured to be inserted through the opening and into the cavity.

9. The surgical device recited in claim 1 , wherein the coating comprises a polymer, the polymer comprising the active pharmaceutical ingredient.

10. The surgical device recited in claim 9 , wherein the polymer is a tyrosine-derived polyarylate.

11. A surgical device configured to surround an implantable medical device, the surgical device comprising:

a collagen membrane; and

a coating covering at least a portion of the membrane, the coating including an active pharmaceutical ingredient,

wherein the coating comprises carboxypeptidase collagen.

12. The surgical device recited in claim 11 , wherein the active pharmaceutical ingredient is selected from the group consisting of a hemostatic agent, rifampin and minocycline, and mixtures thereof.

13. The surgical device recited in claim 12 , wherein the hemostatic agent is tranexamic acid.

14. A surgical device configured to surround an implantable medical device, the surgical device comprising:

a collagen membrane; and

a coating covering at least a portion of the membrane, the coating including an active pharmaceutical ingredient,

wherein the coating comprises carboxypeptidase X collagen,

wherein the membrane comprises a first piece and a second piece that is joined with the first piece, the first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity, the implantable medical device being configured to be inserted through the opening and into the cavity, and

wherein the coating comprises a polymer, the polymer comprising the active pharmaceutical ingredient.

15. The surgical device recited in claim 14 , wherein the active pharmaceutical ingredient is selected from the group consisting of a hemostatic agent, rifampin and minocycline, and mixtures thereof.

16. The surgical device recited in claim 15 , wherein the hemostatic agent is tranexamic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2021
From: NIELSEN, CHRISTIAN S.; CHEN, SEAN; KAMM, ANNE R.; RAY, PAUL C.
To: MEDTRONIC, INC.
Reel/Frame 054829/0855 →
Continuity (1)
Related Publication 20220211922A1 · Jul 7, 2022